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Introduction
Cutaneous vasculitis (CV) are a complex group of conditions in 
children. The most common are IgA vasculitis (IgAV) (formerly 
known as Schonlein-Henoch purpura, (SHP)), which represents 
more than half of the cases, followed by cutaneous small-vessel 
vasculitis (formerly known as hypersensitivity vasculitis). Other 
disorders, such as urticarial vasculitis or ANCA associated 
vasculitis are poorly represented in children1. The global incidence 
is not known2, while incidence of IgAV in children range from 
3–26.7 per 100,0003. Symptoms vary from a cutaneous-limited 
disorder to a systemic disease, and the etiology is not fully 
understood. However in many cases, particularly in IgAV, an 
external trigger is frequently suspected; IgAV in children has been 
frequently associated with a preceding upper respiratory infec-
tion, but no specific pathogen has been identified. It has also been 
linked to antibiotics and other medications3. The reported seasonal 
pattern, with a fall-winter incidence peak, is consistent with the 
hypothesis of an infectious trigger3.
The aims of our study are to describe the incidence of CV in Spain 
and to analyze the temporal trend of CV in the last 11 years, as well 
as it seasonal distribution.
Methods
Hospital discharges with a diagnosis consistent with CV (Inter-
national Classification of Diseases ICD-9 codes hypersensitivity 
angiitis (446.2) and allergic purpura, including SHP (287.0)) in 
Spain from January 2005 to December 2015 were collected from 
the Spanish National Institute of Statistics (INE) databases.
We calculated the overall average incidence of admission per 
100,000 inhabitants during the 11 years in children (from 0 to 18 
years). Moreover, we calculated the annual rate of admission in 
children, and for the temporary trend calculations, a Kendall’s tau 
correlation coefficient. Monthly admission rates were compared 
with Krustal-Wallis test. Statistical analysis were performed with 
R v2.3.
Results
A total of 7304 patients from 0 to 18 years of age were 
discharged from January 2005 to December 2015 with a diagno-
sis of CV. 6991 patients (95%) had a diagnosis of IgAV and 313 
had hypersensitivity angiitis. The yearly incidence in the whole 
group was 7.7 per 100,000. Mean age at diagnosis was 6±3 years 
and 52% were male, with a male to female ratio of 1.02:1. The 
highest rate of admissions was found in the 5–9 year-old group, 
followed by those aged 0–4 years (15.7 and 9.0 admissions per 
100.000, respectively) (Figure 1).
Admissions due to CV followed an annual cyclic pattern 
(Figure 2), with the highest number of daily admissions during 
fall and winter months and the lowest number in summer months. 
This pattern was consistent over the 11 years of study, with a 3-fold 
increase in the number of daily admissions in October compared 
with August (p<<0.001; Figure 3).
The annual analysis showed a downwards trend of the number of 
hospital admissions during the 11-year period of study, in both men 
and women (p=0.01; Figure 4).
Figure 1. Incidence of cutaneous vasculitis across age groups between January 2005 and December 2015. The highest incidence 
occurred in children 5–9 years of age.
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Figure 2. Monthly incidence of cutaneous vasculitis during the period of study (January 2005–December 2015). A cyclic pattern was 
revealed, with a peak during fall and winters months and a nadir in summer.
Figure 3. Average (mean and standard deviation) monthly incidence of cutaneous vasculitis during the period of study (January 
2005–December 2015). The combined analysis confirms the seasonal pattern throughout the period of study.
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Discussion
This is the first population-based study of CV among children 
in Spain. We report the incidence rate of admissions of children 
with CV, defined as IgAV and hypersensitivity angiitis, over 
11 years.
We estimate a yearly incidence of 7.7 cases per 100.000. Data 
on incidences rate on CV are scarce, while previous series on 
IgAV have reported incidences that range from 6.1 in the Dutch 
population4 to 20.4 in the United Kingdom5. Most published series 
report incidences between 10 and 20 cases per 100.000, with some 
discrepancies probably due to the heterogeneity of the criteria 
used and also by the source of identification of cases (those based 
exclusively in hospital discharge data fail to identify children not 
referred to the hospital). The incidence we report in Spanish chil-
dren keeps in line with previous literature, being in the lower 
part of the range. Our estimates are based on hospitalized cases, 
which might somewhat underestimate true incidence. However, 
we feel our estimated incidence should be close to the true inci-
dence, as most cases are attended to at a hospital, at least in western 
countries. This idea is supported by a US study reporting that 
only 10% of children with IgAV were reported exclusively by pri-
mary care physicians6 and by a UK study showing that only 3% of 
IgAV cases were reported by general practitioners5.
IgAV mainly affects children between 3 and 12 years of age3, with 
a mean age of 5–6 years in most paediatric series6–8. A slightly 
Figure 4. Average annual incidence of cutaneous vasculitis during the study period (January 2005–December 2015). A downwards 
trend in the overall incidence during the period of study was observed.
male predominance has been reported, with a male to female ratio 
of up to 1.8:15–7, while others reported that cases were equally 
distributed8, or even a subtle female predominance9. In our case, we 
found a mean age of 6 years with no differences in sex distribution.
We found a remarkable seasonal variation in the frequency of CV. 
This is in line with other studies showing that IgAV has a seasonal 
distribution, with a peak during fall and winter and a nadir during 
summer months3,10. This keeps in line with a commonly reported 
upper respiratory infection preceding the onset of the purpura, 
and a possible infectious trigger for the disease. Moreover, this 
increase during fall-winter time could also be related with 
atmospheric circulation patterns, as recently suggested for 
Kawasaki disease11.
Our annual analysis showed a downwards trend of the number of 
hospital admissions during the period of study. A similar trend 
has been reported previously. Okubo et al.6 found a significant 
decreasing trend, with a total annual hospitalization rate of 2.45 per 
100,000 children in 2003, falling to 1.89 per 100,000 children in 
2012. This decrease could indicate a tendency to treat patients with 
IgAV in outpatient clinics, but also could reflect a real decrease in 
the incidence of the disease.
In summary, we have estimated an incidence of a 7.7 cases per 
100,000 CV in children in Spain. CV-related hospitalization rates 
have a marked seasonal pattern, with a peak in fall and winter and a 
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nadir in summer months. Children between 5 to 9 years of age are 
most frequently affected. There is a decreasing trend in CV-related 
hospitalization, the cause of which should be further assessed.
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